logo

Novabay Pharmaceuticals Inc. (NBY)



Trade NBY now with
  Date
  Headline
3/23/2017 4:14:57 PM NovaBay Pharmaceuticals Q4 Loss/share $0.13 Vs. Loss $1.26 Year Ago
1/9/2017 6:52:08 AM NovaBay Expects Avenova Sales For Q4 To Exceed $3.8 Mln
9/19/2016 6:54:13 AM NovaBay Pharma’ Auriclosene Demonstrates Significant Results In Phase 2b Study
9/12/2016 6:52:20 AM NovaBay Pharma's Neutrox Product Line Gets CE Mark, ISO Certification For European Union
8/11/2016 4:47:39 PM NovaBay Pharma Q2 Loss Per Share $0.36 Vs Loss $1.84 Last Year
6/13/2016 6:53:23 AM NovaBay Appoints Mark Sieczkarek As President And CEO
4/6/2016 6:52:27 AM NovaBay Pharma Announces Agreement For Nearly $12 Mln In Two-Tranche Private Placement
1/11/2016 6:53:46 AM NovaBay Expects Q4 U.S. Sales Of Its Prescription Avenova Lid And Lash Cleanser To Exceed $1.5 Mln
11/19/2015 6:03:55 AM NovaBay Pharma Q3 Net Loss $5.2 Mln Or $0.07/shr Vs. Net Loss $4.2 Mln Or $0.08/shr Last Year
11/19/2015 6:02:57 AM NovaBay Pharma Says Appoints Chairman Mark Sieczkarek As Interim President And CEO
11/4/2015 7:12:55 AM NovaBay Completes 34 Patient Phase 2B Clinical Study
10/23/2015 9:26:15 AM NovaBay Pharma Prices Underwritten Public Offering Of 12.3 Mln Shares
9/24/2015 7:10:08 AM NovaBay Announces Partnership With ALPHAEON To Bring Avenova To Ophthalmologists And Patients Across US
9/2/2015 7:03:20 AM NovaBay Pharmaceuticals Signs Distribution Agreement To Make Avenova Available In New Zealand
8/13/2015 4:50:00 PM NovaBay Pharmaceuticals Posts Q2 Loss/share Of $0.07 Vs. Loss $0.06 Year Ago
6/4/2015 7:09:12 AM NovaBay Pharma Gets 510(k) Clearance From FDA To Market Its Novel Intelli-Case With Hydrogen Peroxide Solutions